Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

The post Teladoc Stock Falls after Q2 Earnings Then Recovers appeared first on Millennial Money. Shares of Teladoc Health (NYSE: TDOC) weren't looking so healthy on Wednesday morning after the company reported second quarter earnings on Tuesday evening. Sales skyrocketed as demand for telehealth services remained strong, but unfortunately so did Teladoc's net losses as the company recognized expenses related to the merger with Livongo, which was finalized in late

Teladoc Stock Falls after Q2 Earnings Then Recovers

Teladoc Health Inc. (NYSE:TDOC) shares pulled back 2% Wednesday morning after several analysts lowered their expectations. The company reported its fiscal second-quarter results on Tuesday, missing analyst expectations on earnings.

Analysts are pessimistic on Teladoc amid slowing growth: should you buy or sell?

Teladoc Health's (TDOC) Q2 earnings endure high expenses. Guidance shows tapering of growth.

Teladoc Health (TDOC) Q2 Loss Wider Than Expected, Worsen Y/Y

Even if the company can grow to the moon, it might leave shareholders behind.

Will Teladoc Be a Trillion-Dollar Stock by 2040?

Teladoc Health Inc (NYSE: TDOC) is trading significantly lower Wednesday after the company announced its second-quarter financial results. Teladoc Health reported a quarterly earnings loss of 86 cents per share, which came in below the estimate for a loss of 56 cents per share.

What's Going On With Teladoc Health's Stock Today

Recent acquisitions, new client wins, and product execution helped the telehealth specialist more than double its revenue year over year.

Teladoc Quarterly Revenue Exceeds $500 Million

Teladoc Health Inc (NYSE: TDOC) posted a wider than expected net loss in Q2 of $133.8 million, or $(0.86) a share, compared with $25.7 million or $(0.34) posted a year ago primarily due to expenses related to the large-scale acquisition of Livongo Health. On average, analysts estimated a net loss of $(0.56) although cautioned that this "may not compare" to the actual result.

Teladoc Health Stock Drops After Reporting Wider Than Expected Q2 Net Loss; Analysts Lower Price Target

Teladoc Health, Inc. (TDOC) CEO Jason Gorevic on Q2 2021 Results - Earnings Call Transcript

The company's latest earnings report sure features a lot of red ink.

Why Teladoc Health Stock Is Diving in After-Hours Trading Today

Teladoc Health Inc. shares fell more than 7% in the extended session Tuesday after the telemedicine company reported a wider-than-expected second-quarter loss and guided for a wider per-share loss for the year than analysts forecast. Teladoc said it lost $133.8 million, or 86 cents a share, in the second quarter, compared with a loss of $25.7 million, or 34 cents a share, in the year-ago period.

Teladoc stock drops after telemedicine company reports wider quarterly loss

Shares of Teladoc Health (NYSE:TDOC) fell in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 152.94% over the past year to ($0.86), which missed the estimate of ($0.56).

Recap: Teladoc Health Q2 Earnings

PURCHASE, NY, July 27, 2021 (GLOBE NEWSWIRE) --  Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the quarter ended June 30, 2021.

Teladoc Health Reports Second-Quarter 2021 Results, Raises Full-Year Revenue Guidance

FuboTV

If you have ready my past articles, you know I generally like to write about companies I am bullish on.

2 FinTwit Stocks I'm Bearish On

American Airlines

Apple

BlackBerry

Carnival

Canoo

Zoom Video

The recent drop was a good reminder that risk happens fast. These seven stocks to sell are overvalued and could slump in the next correction.

7 Overvalued Stocks to Sell Now Ahead of a Potential Correction

Airbnb

Lemonade

These three stocks are down, but that doesn't mean anything is wrong with their businesses.

3 Beaten-Down Stocks That Could Be Great Long-Term Bargains

Doximity

Teladoc Health was the first mover, but it's no longer top dog by some standards.

Better Healthcare Stock: Teladoc vs. Doximity

TDOC's stock price has under-performed in 2021 year-to-date; its shares are down -23% in this year thus far, as compared to a +140% jump in its share price last year. TDOC stock dropped significantly in the first seven months of 2021, because of concerns relating to slower revenue growth and competitive threats.

Why Is Teladoc Health Stock Down In The First Half Of 2021? How To Interpret This

It's time to get your portfolio ready for the next market crash.

Got $2,500? 2 Top Stocks to Buy and Hold for a Lifetime

Teladoc's (TDOC) Q2 results are likely to reflect a rise in revenues but overall tepid demand as patients started visiting doctors' clinics for in-person checkups.

Will Teladoc (TDOC) Q2 Earnings Show Weak Telehealth Demand?

The technology leader in virtual doctor visits could benefit from spiking coronavirus cases.

Why Teladoc Stock Is Rising More Than the Market Today

Block

Trupanion

The path to financial independence involves buying great companies and trusting your thesis.

4 Stocks That Can Make the Average Investor a Millionaire

Our valuation analysis indicates that the stock is undervalued.

Teladoc Health: Great Long-Term Success Opportunity For Investors

Microsoft

Teladoc Health (TDOC) collaborates with Microsoft in a bid to ease administrative workflows for clinicians and offer enhanced virtual care to patients.

Teladoc (TDOC), Microsoft Team Up to Offer Better Virtual Care

Yes, Tesla has been the bigger winner lately. But the future could look different than the past.

3 Reasons Teladoc Stock Is a Better Buy Than Tesla

In the latest trading session, Teladoc (TDOC) closed at $146.21, marking a -1.77% move from the previous day.

News for Teladoc Stock (TDOC)